Insurance Discrimination, Companion Animal Harm, and Domestic Violence and Abuse — Double Jeopardy in the UK
Violence Against Women · 2024
DOI: 10.1177/10778012231176201 ↗Kurz gefasst
Fachartikel in der Zeitschrift Violence Against Women, 2024. Verfasst von Di Turgoose und 2 weiteren Autor:innen. Beteiligte Einrichtung: De Montfort University, Leicester, UK. Hauptthemen laut MEDLINE: Domestic Violence, Pets. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Prompted by Signal et al.’s study, this research examines UK “Pet Insurance” policies to see if and how experiencing domestic violence and abuse (DVA) in interspecies households is excluded under insurance policies terms. Situating our findings within the existing literature on human and companion animal victims of DVA, we discuss the implications for improving cross-reporting and multi-agency action to protect and prevent harm to humans and companion animal victims of DVA. In turn we identify a series of recommendations to combat discrimination in insurance, set out in our conclusion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- De Montfort University, Leicester, UK.
ORCID-Profile: Ruth E McKie
Zitieren
APA
Turgoose, D., McKie, R. E., & Connelly, P. (2024). Insurance Discrimination, Companion Animal Harm, and Domestic Violence and Abuse — Double Jeopardy in the UK. Violence Against Women. https://doi.org/10.1177/10778012231176201
Vancouver
Turgoose D, McKie RE, Connelly P. Insurance Discrimination, Companion Animal Harm, and Domestic Violence and Abuse — Double Jeopardy in the UK. Violence Against Women. 2024. doi:10.1177/10778012231176201
BibTeX
@article{Turgoose2024,
author = {Turgoose, Di and McKie, Ruth E and Connelly, Paris},
title = {Insurance Discrimination, Companion Animal Harm, and Domestic Violence and Abuse — Double Jeopardy in the UK},
journal = {Violence Against Women},
year = {2024},
doi = {10.1177/10778012231176201}
}
EUVIMED